Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver). A novel strategy for modifying excitability
about
Novel functional properties of Ca(2+) channel beta subunits revealed by their expression in adult rat heart cellsGene and cell therapies for the failing heart to prevent sudden arrhythmic deathOverexpression of a human potassium channel suppresses cardiac hyperexcitability in rabbit ventricular myocytes.Expression of inwardly rectifying potassium channels by an inducible adenoviral vector reduced the neuronal hyperexcitability and hyperalgesia produced by chronic compression of the spinal ganglion.Molecular dissection of cardiac repolarization by in vivo Kv4.3 gene transferMolecular enhancement of porcine cardiac chronotropy.Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1.Ultrarapid, highly efficient viral gene transfer to the heartModification of cellular communication by gene transfer.Innovative approaches to anti-arrhythmic drug therapy.Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo.Enhancement of murine cardiac chronotropy by the molecular transfer of the human beta2 adrenergic receptor cDNA.Programming and isolation of highly pure physiologically and pharmacologically functional sinus-nodal bodies from pluripotent stem cells.Adenovirus-mediated transfer of CCAAT/enhancer-binding protein-alpha identifies a dominant antiproliferative role for this isoform in hepatocytes.Generation of murine cardiac pacemaker cell aggregates based on ES-cell-programming in combination with Myh6-promoter-selectionVirus-mediated modification of cellular excitability.Suppression of neuronal and cardiac transient outward currents by viral gene transfer of dominant-negative Kv4.2 constructs.Specific Cell (Re-)Programming: Approaches and Perspectives.
P2860
Q24642102-2D54BC3A-C450-4B80-A9FA-54F9A644FE2DQ26865425-4AB6CDCB-BB4D-432C-BA7F-3A7B8BD72FBAQ33844131-D50B2387-826A-4706-A81E-543822A4916CQ34221576-24BC2250-EE35-4142-896D-C776E8979C84Q34432506-CB3E11E3-F0EA-4085-9698-134D0A0CDA54Q35381580-02D4401B-29C6-425E-8163-C3F6D0E1E51CQ35874546-86C32C94-B718-4353-9188-BBA7753F5458Q36144261-37EC79B3-B33A-45F5-A9CD-5FF97BC3BF2AQ36225135-6645AF90-DCEE-4BAE-86F9-D354BF68CF8CQ36670460-1C9ABB1C-EAE0-4EFA-BDCF-4301E9AE888DQ37371503-CC245E82-8C4D-453C-B130-7D83B0BD1AABQ37377398-63FE83B5-1931-437A-A9F9-72DA4641717BQ38983973-0CA05DC2-056F-4B42-8FC6-F5C746052E8BQ41213220-85EB3612-01EB-4D1A-A4E5-C55AFCAE1381Q41448207-42296AE9-6CDF-4A2B-BA67-D881C8B26B1FQ43467543-2422BA2A-5121-45CB-A87A-EDD31B7D3A51Q44798839-56FA18AF-155E-4C31-ACB7-8D29ED5A9F23Q50085975-83866909-D790-4B0E-B8F3-CBA3C0D73D91
P2860
Adenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver). A novel strategy for modifying excitability
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Adenovirus-mediated expression ...... egy for modifying excitability
@ast
Adenovirus-mediated expression ...... egy for modifying excitability
@en
type
label
Adenovirus-mediated expression ...... egy for modifying excitability
@ast
Adenovirus-mediated expression ...... egy for modifying excitability
@en
prefLabel
Adenovirus-mediated expression ...... egy for modifying excitability
@ast
Adenovirus-mediated expression ...... egy for modifying excitability
@en
P2093
P2860
P356
P1476
Adenovirus-mediated expression ...... egy for modifying excitability
@en
P2093
J H Lawrence
N Chiamvimonvat
P2860
P304
P356
10.1172/JCI118103
P407
P577
1995-08-01T00:00:00Z